Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report)’s share price hit a new 52-week high during trading on Wednesday after Bank of America raised their price target on the stock from $18.00 to $21.

Raising its price target on the shares to $21, reports The Fly, BofA nonetheless reiterated an "underperform" ( i.e., sell) ...

Israel says it has identified two of the dead bodies returned by Hamas on Thursday as Ariel and Kfir Bibas – but tests show ...

Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last ...

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

Alright folks, Kylie Kelce is back at it with another revelation about her relationship with former Philadelphia Eagles ...

These his-and-hers retreats by Kristin Paton Interiors are so much more than pass-through areas at the Kips Bay Decorator ...

BofA raised the firm’s price target on Hims & Hers to $21 from $18 and keeps an Underperform rating on the shares. The firm increased Q4 ...

Hims & Hers' acquisition of Trybe Labs broadens its treatment range and enhances its competitive edge through increased data ...

Blake Lively “confided” in a mutual friend of hers and Justin Baldoni’s that the “It Ends With Us” director was acting like a ...

She raised the baby for five months before giving him to his biological parents after realizing she could not win the custody ...